Safety and Efficacy of Boceprevir/Peginterferon Alfa-2a/Ribavirin in Interleukin-28B CC Allele-Positive Chronic Hepatitis C Virus (HCV) Genotype 1 Participants (P07755)

Inclusion Criteria: * Is ≥ 40 kg and ≤ 125 kg. * Documented CHC genotype 1 with HCV RNA ≥10,000 International Units (IU)/mL * Has IL-28B CC allele gene * Has had a liver biopsy without evidence of cirrhosis and hepatocellular carcinoma (non-invasive fibroscan and Fibrotest can also be used for staging of liver disease). Exclusion Criteria: * Co-infection with the human immunodeficiency virus (HIV) or hepatitis B virus (Hepatitis B surface antigen \[HBsAg\] or HIV positive). * Previously treated with an interferon and ribavirin regimen or HCV direct acting antiviral regimen. * Treatment for hepatitis C with any investigational medication, or prior treatments with herbal remedies with known hepatotoxicity * Receiving any medication(s) within 2 weeks prior to the Day 1 visit that are highly dependent on Cytochrome P450 3A4 (CYP3A4/5) for clearance, and for which elevated plasma concentrations could be associated with serious and/or life-threatening events * Participation in any other clinical trial within 30 days of the screening visit in this trial or intention to participate in another clinical trial during participation in this trial. * Evidence of decompensated liver disease or hepatocellular carcinoma (HCC) * Is diabetic and/or hypertensive with significant retinopathy * Has any known medical condition that could interfere with the participation in and completion of the trial including immunologically-mediated disease, chronic pulmonary disease, or current or history of any clinically significant cardiac abnormalities/dysfunction. * Evidence of active or suspected malignancy, or a history of malignancy, within the last 5 years * Hemoglobin \<12 g/dL for females and \<13 g/dL for males * Neutrophils \<1,500/mm\^3, or \<1,200/mm\^3 for participants of African descent * Platelets \<150,000/mm\^3 * Direct bilirubin \>1.5 x upper limit of normal (ULN) of the laboratory reference range.